Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years — Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States, 2022
Open accessAbstract
Problem/Condition: Autism spectrum disorder (ASD). Period Covered: 2022. Description of System: The Autism and Developmental Disabilities Monitoring Network is an active surveillance program that estimates prevalence and characteristics of ASD and monitors timing of ASD identification among children aged 4 and 8 years. In 2022, a total of 16 sites (located in Arizona, Arkansas, California, Georgia, Indiana, Maryland, Minnesota, Missouri, New Jersey, Pennsylvania, Puerto Rico, Tennessee, Texas [two sites: Austin and Laredo], Utah, and Wisconsin) conducted surveillance for ASD among children aged 4 and 8 years and suspected ASD among children aged 4 years. Surveillance included children who lived in the surveillance area at any time during 2022. Children were classified as having ASD if they ever received 1) an ASD diagnostic statement in a comprehensive developmental evaluation, 2) autism special education eligibility, or 3) an ASD International Classification of Diseases, Ninth Revision (ICD-9) code in the 299 range or International Classification of Diseases, Tenth Revision (ICD-10) code of F84.0, F84.3, F84.5, F84.8, or F84.9. Children aged 4 years were classified as having suspected ASD if they did not meet the case definition for ASD but had an evaluator's suspicion of ASD documented in a comprehensive developmental evaluation. Results: Among children aged 8 years in 2022, ASD prevalence was 32.2 per 1,000 children (one in 31) across the 16 sites, ranging from 9.7 in Texas (Laredo) to 53.1 in California. The overall observed prevalence estimate was similar to estimates calculated using Bayesian hierarchical and random effects models. ASD was 3.4 times as prevalent among boys (49.2) than girls (14.3). Overall, ASD prevalence was lower among non-Hispanic White (White) children (27.7) than among Asian or Pacific Islander (A/PI) (38.2), American Indian or Alaska Native (AI/AN) (37.5), non-Hispanic Black or African American (Black) (36.6), Hispanic or Latino (Hispanic) (33.0), and multiracial children (31.9). No association was observed between ASD prevalence and neighborhood median household income (MHI) at 11 sites; higher ASD prevalence was associated with lower neighborhood MHI at five sites.Record abstraction was completed for 15 of the 16 sites for 8,613 children aged 8 years who met the ASD case definition. Of these 8,613 children, 68.4% had a documented diagnostic statement of ASD, 67.3% had a documented autism special education eligibility, and 68.9% had a documented ASD ICD-9 or ICD-10 code. All three elements of the ASD case definition were present for 34.6% of children aged 8 years with ASD.Among 5,292 (61.4% of 8,613) children aged 8 years with ASD with information on cognitive ability, 39.6% were classified as having an intellectual disability. Intellectual disability was present among 52.8% of Black, 50.0% of AI/AN, 43.9% of A/PI, 38.8% of Hispanic, 32.7% of White, and 31.2% of multiracial children with ASD. The median age of earliest known ASD diagnosis was 47 months and ranged from 36 months in California to 69.5 months in Texas (Laredo).Cumulative incidence of ASD diagnosis or eligibility by age 48 months was higher among children born in 2018 (aged 4 years in 2022) than children born in 2014 (aged 8 years in 2022) at 13 of the 15 sites that were able to abstract records. Overall cumulative incidence of ASD diagnosis or eligibility by age 48 months was 1.7 times as high among those born in 2018 compared with those born in 2014 and ranged from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico. Among children aged 4 years, for every 10 children meeting the case definition of ASD, one child met the definition of suspected ASD.Children with ASD who were born in 2018 had more evaluations and identification during ages 0-4 years than children with ASD who were born in 2014 during the 0-4 years age window, with an interruption in the pattern in early 2020 coinciding with onset of the COVID-19 pandemic.Overall, 66.5% of children aged 8 years with ASD had a documented autism test. Use of autism tests varied widely across sites: 24.7% (New Jersey) to 93.5% (Puerto Rico) of children aged 8 years with ASD had a documented autism test in their records. The most common tests documented for children aged 8 years were the Autism Diagnostic Observation Schedule, Autism Spectrum Rating Scales, Childhood Autism Rating Scale, Gilliam Autism Rating Scale, and Social Responsiveness Scale. Interpretation: Prevalence of ASD among children aged 8 years was higher in 2022 than previous years. ASD prevalence was higher among A/PI, Black, and Hispanic children aged 8 years than White children aged 8 years, continuing a pattern first observed in 2020. A/PI, Black, and Hispanic children aged 8 years with ASD were also more likely than White or multiracial children with ASD to have a co-occurring intellectual disability. Identification by age 48 months was higher among children born in 2018 com
AI snapshot
Written from the paper’s full text.
TL;DR
In 2022, ASD prevalence among children aged 8 years across 16 ADDM Network sites was 32.2 per 1,000 (one in 31), with wide site variation and higher prevalence among several racial and ethnic groups than White children. Early identification by age 48 months was 1.7 times as high among children born in 2018 compared with those born in 2014.
Key findings
- Among children aged 8 years, ASD prevalence was 32.2 per 1,000, ranging from 9.7 in Texas (Laredo) to 53.1 in California; prevalence was 49.2 per 1,000 among boys and 14.3 among girls (male-to-female ratio 3.4).
- Prevalence was lower among White children (27.7) than A/PI (38.2), AI/AN (37.5), Black (36.6), Hispanic (33.0), and multiracial children (31.9).
- Among 5,292 children aged 8 years with ASD and cognitive data, 39.6% had intellectual disability (IQ ≤70); median age of earliest known ASD diagnosis was 47 months.
- Cumulative incidence of ASD diagnosis or eligibility by age 48 months was 1.7 times as high among children born in 2018 (22.6 per 1,000) compared with children born in 2014 (13.1 per 1,000); suspected ASD among children aged 4 years was 3.1 per 1,000, or one suspected case for every 10 children meeting ASD case definition.
Methods
- Active surveillance in 16 sites in 2022 among children aged 4 and 8 years, using health and education records; ASD case definition required an ASD diagnostic statement, autism special education eligibility, or qualifying ICD-9/ICD-10 code, with suspected ASD defined for children aged 4 years.
- Record abstraction was completed for 15 sites for 8,613 children aged 8 years who met the ASD case definition; analyses included prevalence by sex, race and ethnicity, neighborhood median household income, and social vulnerability index.
- Prevalence was calculated per 1,000 children, with Bayesian hierarchical and random-effects models also used for overall estimates; cumulative incidence by age 48 months and monthly evaluation/identification patterns were compared between birth cohorts.
Limitations
- The paper states that ADDM surveillance populations are not nationally representative, overall estimates do not capture full community variability, and data quality depends on availability and completeness of records, which vary by site and source.
- The paper also states that sources reviewed generally do not include private schools or primary care providers, and that the surveillance definition of intellectual disability is not the same as a clinical diagnosis; IQ in young children may lack stability and adaptive behavior assessments are often absent.
- Evident from the text: Indiana was excluded from record-abstraction analyses because ASD diagnostic statement data were unavailable, and several site-specific estimates were suppressed because relative standard error was ≥30%.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 21 cited sources checked · 0 supported · 0 flagged
- Findingown data
The most common tests documented for children aged 8 years were the Autism Diagnostic Observation Schedule, Autism Spectrum Rating Scales, Childhood Autism Rating Scale, Gilliam Autism Rating Scale, and Social Responsiveness Scale.
“The most common tests documented for children aged 8 years were the Autism Diagnostic Observation Schedule, Autism Spectrum Rating Scales, Childhood Autism Rating Scale, Gilliam Autism Rating Scale, and Social Responsiveness Scale.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
ASD prevalence was higher among A/PI, Black, and Hispanic children aged 8 years than White children aged 8 years.
“ASD prevalence was higher among A/PI, Black, and Hispanic children aged 8 years than White children aged 8 years, continuing a pattern first observed in 2020.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Among children aged 8 years in 2022, ASD prevalence was 32.2 per 1,000 children (one in 31) across the 16 ADDM sites.
“Among children aged 8 years in 2022, ASD prevalence was 32.2 per 1,000 children (one in 31) across the 16 sites, ranging from 9.7 in Texas (Laredo) to 53.1 in California.”
- Also stated in: § ASD Prevalence Among Children Aged 8 Years · plain
“The overall observed ASD prevalence was 32.2 per 1,000 (one in 31) children aged 8 years and ranged from 9.7 in Texas (Laredo) to 53.1 in California (Table 1).”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Rests on an assumption: Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
- Also stated in: § ASD Prevalence Among Children Aged 8 Years · plain
- Findingown data
Overall ASD prevalence among children aged 8 years was lower among non-Hispanic White children (27.7 per 1,000) than among A/PI (38.2), AI/AN (37.5), Black (36.6), Hispanic (33.0), and multiracial children (31.9).
“Overall, ASD prevalence was lower among non-Hispanic White (White) children (27.7) than among Asian or Pacific Islander (A/PI) (38.2), American Indian or Alaska Native (AI/AN) (37.5), non-Hispanic Black or African American (Black) (36.6), Hispanic or Latino (Hispanic) (33.0), and multiracial children (31.9).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Children with ASD born in 2018 had more evaluations and identification during ages 0-4 years than children with ASD born in 2014 during the 0-4 years age window.
“Children with ASD who were born in 2018 had more evaluations and identification during ages 0–4 years than children with ASD who were born in 2014 during the 0–4 years age window, with an interruption in the pattern in early 2020 coinciding with onset of the COVID-19 pandemic.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
ASD was 3.4 times as prevalent among boys as girls among children aged 8 years in 2022.
“ASD was 3.4 times as prevalent among boys (49.2) than girls (14.3).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Among 5,292 children aged 8 years with ASD with information on cognitive ability, 39.6% were classified as having an intellectual disability.
“Among 5,292 (61.4% of 8,613) children aged 8 years with ASD with information on cognitive ability, 39.6% were classified as having an intellectual disability.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
There was an interruption in the pattern of evaluations and identification in early 2020 coinciding with onset of the COVID-19 pandemic.
“Children with ASD who were born in 2018 had more evaluations and identification during ages 0–4 years than children with ASD who were born in 2014 during the 0–4 years age window, with an interruption in the pattern in early 2020 coinciding with onset of the COVID-19 pandemic.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Overall cumulative incidence of ASD diagnosis or eligibility by age 48 months was 1.7 times as high among children born in 2018 compared with those born in 2014.
“Overall cumulative incidence of ASD diagnosis or eligibility by age 48 months was 1.7 times as high among those born in 2018 compared with those born in 2014 and ranged from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The median age of earliest known ASD diagnosis among children aged 8 years with ASD was 47 months.
“The median age of earliest known ASD diagnosis was 47 months and ranged from 36 months in California to 69.5 months in Texas (Laredo).”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Use of autism tests varied widely across sites, from 24.7% in New Jersey to 93.5% in Puerto Rico of children aged 8 years with ASD.
“Use of autism tests varied widely across sites: 24.7% (New Jersey) to 93.5% (Puerto Rico) of children aged 8 years with ASD had a documented autism test in their records.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The overall observed ASD prevalence estimate among children aged 8 years was similar to estimates calculated using Bayesian hierarchical and random effects models.
“The overall observed prevalence estimate was similar to estimates calculated using Bayesian hierarchical and random effects models.”
Quote in the paperNot a substantial claim - Findingown data
A/PI, Black, and Hispanic children aged 8 years with ASD were more likely than White or multiracial children with ASD to have a co-occurring intellectual disability.
“A/PI, Black, and Hispanic children aged 8 years with ASD were also more likely than White or multiracial children with ASD to have a co-occurring intellectual disability.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Higher ASD prevalence was associated with lower neighborhood median household income at five sites.
“higher ASD prevalence was associated with lower neighborhood MHI at five sites.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
All three elements of the ASD case definition were present for 34.6% of children aged 8 years with ASD.
“All three elements of the ASD case definition were present for 34.6% of children aged 8 years with ASD.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The median age of earliest known ASD diagnosis ranged from 36 months in California to 69.5 months in Texas (Laredo).
“The median age of earliest known ASD diagnosis was 47 months and ranged from 36 months in California to 69.5 months in Texas (Laredo).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
ASD prevalence among children aged 8 years in 2022 ranged from 9.7 per 1,000 in Texas (Laredo) to 53.1 per 1,000 in California.
“ranging from 9.7 in Texas (Laredo) to 53.1 in California.”
- Also stated in: § ASD Prevalence Among Children Aged 8 Years · plain
“and ranged from 9.7 in Texas (Laredo) to 53.1 in California (Table 1).”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Rests on an assumption: Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
- Also stated in: § ASD Prevalence Among Children Aged 8 Years · plain
- Findingown data
Identification by age 48 months was higher among children born in 2018 compared with children born in 2014.
“Identification by age 48 months was higher among children born in 2018 compared with children born in 2014, suggesting increased early identification consistent with historical patterns.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
No association was observed between ASD prevalence and neighborhood median household income at 11 sites.
“No association was observed between ASD prevalence and neighborhood median household income (MHI) at 11 sites;”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The ratio of cumulative incidence by age 48 months between children born in 2018 and 2014 ranged from 1.4 in Arizona and Georgia to 3.1 in Puerto Rico.
“Overall cumulative incidence of ASD diagnosis or eligibility by age 48 months was 1.7 times as high among those born in 2018 compared with those born in 2014 and ranged from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Overall, 66.5% of children aged 8 years with ASD had a documented autism test.
“Overall, 66.5% of children aged 8 years with ASD had a documented autism test.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Among children aged 4 years, for every 10 children meeting the case definition of ASD, one child met the definition of suspected ASD.
“Among children aged 4 years, for every 10 children meeting the case definition of ASD, one child met the definition of suspected ASD.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
Cumulative incidence of ASD diagnosis or eligibility by age 48 months was higher among children born in 2018 than children born in 2014 at 13 of the 15 sites that were able to abstract records.
“Cumulative incidence of ASD diagnosis or eligibility by age 48 months was higher among children born in 2018 (aged 4 years in 2022) than children born in 2014 (aged 8 years in 2022) at 13 of the 15 sites that were able to abstract records.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The percentage of children with ASD who had a documented ICD code was 68.9% (range 40.9% [Maryland] to 88.7% [Pennsylvania]).
“The percentage of children with ASD who had a documented ICD code was 68.9% (range = 40.9% [Maryland] to 88.7% [Pennsylvania]).”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, 12.2% had a documented GARS test (range 1.4%-60.1%).
“Gilliam Autism Rating Scale (GARS) (12.2% overall; range = 1.4%–60.1%)”
Quote in the paperNot a substantial claim - Findingown data
Among the 5,887 children aged 8 years with ASD who had an evaluation containing an ASD diagnostic statement, the median age at earliest known diagnosis was 47 months (range 36 months in California to 69.5 months in Texas [Laredo]).
“Among the 5,887 children aged 8 years with ASD who had an evaluation containing an ASD diagnostic statement, the median age at earliest known diagnosis was 47 months (range = 36 months in California to 69.5 months in Texas [Laredo])”
Quote in the paperSubstantial claim - Findingown data
For 11 sites, ASD prevalence was not associated with neighborhood median household income (MHI).
“For 11 sites, ASD prevalence was not associated with neighborhood MHI”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD who had data on cognitive ability, 24.2% were classified in the borderline range (IQ 71-85).
“24.2% were classified in the borderline range (IQ = 71–85)”
Quote in the paperNot a substantial claim - Findingown data
Prevalence was similar between 2020 and 2022 at two sites (Arizona and Utah).
“Prevalence was similar between 2020 and 2022 at two sites (Arizona and Utah).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Rests on an assumption: Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
- Findingown data
The percentage of children with cognitive data available who were classified as having intellectual disability varied widely among sites (range 24.8% in Puerto Rico to 80.0% in Texas [Laredo]).
“The percentage of children with cognitive data available who were classified as having intellectual disability varied widely among sites (range = 24.8% in Puerto Rico to 80.0% in Texas [Laredo]).”
Quote in the paperNot a substantial claim - Findingown data
Among all 8,613 children with ASD in the 15 sites that completed record abstraction, 9.4% met the case definition through having only an ICD code.
“among all 8,613 children with ASD in the 15 sites that completed record abstraction, 9.4% met the case definition through having only an ICD code.”
Quote in the paperNot a substantial claim - Findingown data
Among 7,227 children aged 8 years with ASD and available evaluations, 50.3% were evaluated by age 36 months (range 42.2% in Missouri to 63.6% in Pennsylvania).
“Among 7,227 children aged 8 years with ASD and available evaluations, 50.3% were evaluated by age 36 months (range = 42.2% in Missouri to 63.6% in Pennsylvania)”
Quote in the paperSubstantial claim - Findingown data
Evidence of heterogeneity of the male-to-female ASD prevalence ratio was observed across sites.
“Evidence of heterogeneity of the male-to-female ratio was observed across sites (Table 2).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
ASD tests varied widely among children aged 4 years by site.
“ASD tests varied widely among children aged 4 years by site”
Quote in the paperNot a substantial claim - Findingown data
Overall, a similar proportion of girls and boys with ASD had intellectual disability (40.4% versus 39.5%, respectively).
“Overall, a similar proportion of girls and boys with ASD had intellectual disability (40.4% versus 39.5%, respectively).”
Quote in the paperNot a substantial claim - Findingown data
Findings using social vulnerability index (SVI) were generally similar: an association between SVI and ASD prevalence was not present at 11 sites.
“Findings using SVI were generally similar: an association between SVI and ASD prevalence was not present at 11 sites”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, the percentage with any documented autism test varied by site from 24.7% in New Jersey to 93.5% in Puerto Rico.
“Autism testing practices varied among sites (Figure 6), ranging from 24.7% (New Jersey) to 93.5% (Puerto Rico) of children with ASD aged 8 years having any autism test documented in their records”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, 24.1% had a documented CARS test (range 10.1%-70.7%).
“Childhood Autism Rating Scale (CARS) (24.1% overall; range = 10.1%–70.7%)”
Quote in the paperNot a substantial claim - Findingown data
There were significant differences for Pearson chi-square tests for proportion of Black versus multiracial or White children with ASD and IQ information available (each comparison p=0.01).
“Significant differences for Pearson chi-square tests for proportion of Black versus multiracial or White children with ASD and IQ information available (each comparison p = 0.01).”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence per 1,000 children aged 8 years based exclusively on documented ASD diagnostic statements was 22.5 overall (range 6.2 in Texas [Laredo] to 42.3 in California).
“ASD prevalence per 1,000 children aged 8 years based exclusively on documented ASD diagnostic statements was 22.5 overall (range = 6.2 in Texas [Laredo] to 42.3 in California)”
Quote in the paperNot a substantial claim - Findingown data
Overall AI/AN ASD prevalence per 1,000 among children aged 8 years was 37.5 (95% CI 26.7-52.4).
“Overall AI/AN autism spectrum disorder prevalence per 1,000 was 37.5 (26.7–52.4).”
Quote in the paperNot a substantial claim - Findingown data
By race and ethnicity, Black children had a higher proportion of co-occurring intellectual disability (52.8%) than all other groups except AI/AN (50.0%) children.
“By race and ethnicity, Black children had a higher proportion of co-occurring intellectual disability (52.8%) than all other groups except AI/AN (50.0%) children.”
Quote in the paperNot a substantial claim - Findingown data
Children with ASD and intellectual disability had a lower median age at diagnosis (43 months) than children without an intellectual disability (49 months).
“Children with ASD and intellectual disability had a lower median age at diagnosis (43 months) than children without an intellectual disability (49 months).”
Quote in the paperNot a substantial claim - Findingown data
Among the 15 sites that completed record abstraction, the percentage of children with ASD who had a documented ASD diagnostic statement was 68.4% overall (range 41.2% in Texas [Austin] to 95.0% in Puerto Rico).
“Among the 15 sites that completed record abstraction, the percentage of children with ASD who had a documented ASD diagnostic statement was 68.4% overall (range = 41.2% in Texas [Austin] to 95.0% in Puerto Rico)”
Quote in the paperNot a substantial claim - Findingown data
In March and April 2020, the first 2 months after the COVID-19 pandemic declaration, the number of evaluations and rate of identification per 1,000 children was similar or lower for children born in 2018 compared with children born in 2014.
“In March and April 2020, the first 2 months after the COVID-19 pandemic declaration, this pattern was disrupted, and the number of evaluations and rate of identification per 1,000 children was similar or lower for children born in 2018 compared with children born in 2014.”
Quote in the paperNot a substantial claim - Findingown data
Overall prevalence among children aged 4 years was similar to children aged 8 years in four sites (Maryland, Pennsylvania, Texas [Austin], and Wisconsin).
“similar to children aged 8 years in four sites (Maryland, Pennsylvania, Texas [Austin], and Wisconsin)”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence ranged widely, from 9.7 per 1,000 children aged 8 years in Texas (Laredo) to 53.1 in California.
“ASD prevalence ranged widely, from 9.7 per 1,000 children aged 8 years in Texas (Laredo) to 53.1 in California.”
Quote in the paperSubstantial claim - Findingown data
Of 5,933 children with an ICD code, 86.3% also had a documented ASD diagnostic statement or autism special education eligibility.
“Of 5,933 children with an ICD code, 86.3% also had a documented ASD diagnostic statement or autism special education eligibility”
Quote in the paperNot a substantial claim - Findingown data
For 2022, prevalence per 1,000 children aged 4 years ranged from 12.9 (Indiana) to 60.6 (California).
“For 2022, prevalence per 1,000 children aged 4 years ranged from 12.9 (Indiana) to 60.6 (California)”
Quote in the paperNot a substantial claim - Findingown data
Children born in 2018 had more evaluations and ASD identifications than children born in 2014 when comparing the two groups for most months during the same age window.
“Children born in 2018 had more evaluations and ASD identifications than children born in 2014 when comparing the two groups of children for most months during the same age window”
Quote in the paperNot a substantial claim - Findingown data
Further limiting the comparison to the five sites where site boundaries and data sources were the same between years, the absolute increase in ASD prevalence from 2020 to 2022 was still 6.1 per 1,000 children aged 8 years (22.8% higher).
“Further limiting the comparison to the five sites where site boundaries and data sources were the same between years, the absolute increase in ASD prevalence from 2020 to 2022 was still 6.1 per 1,000 children aged 8 years (22.8% higher) (Supplementary Table 2, https://stacks.cdc.gov/view/cdc/177099#tabs-3).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Rests on an assumption: Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
- Findingown data
Children born in 2018 (aged 4 years in 2022) had 1.7 times the cumulative incidence of ASD diagnosis or eligibility by age 48 months as children born in 2014 (aged 8 years in 2022) (22.6 per 1,000 compared with 13.1).
“Children born in 2018 (aged 4 years in 2022) had 1.7 times the cumulative incidence of ASD diagnosis or eligibility by age 48 months as children born in 2014 (aged 8 years in 2022) (22.6 per 1,000 children compared with 13.1)”
Quote in the paperSubstantial claim - Findingown data
A/PI (43.9%) and Hispanic (38.8%) children had higher proportions of co-occurring intellectual disability than multiracial (31.2%) and White children (32.7%).
“A/PI (43.9%) and Hispanic (38.8%) children had higher proportions of co-occurring intellectual disability than multiracial (31.2%) and White children (32.7%).”
Quote in the paperNot a substantial claim - Findingown data
Identification by age 48 months was similar between children born in 2014 and 2018 in Minnesota and Texas (Austin).
“Identification by age 48 months was similar between children born in 2014 and 2018 in Minnesota and Texas (Austin).”
Quote in the paperNot a substantial claim - Findingown data
Overall prevalence among children aged 4 years was higher than among children aged 8 years in five sites (California, New Jersey, Puerto Rico, Tennessee, and Texas [Laredo]).
“higher than among children aged 8 years in five sites (California, New Jersey, Puerto Rico, Tennessee, and Texas [Laredo]).”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, 30.2% had a documented ASRS test (range 0.3%-64.5%).
“Autism Spectrum Rating Scales (ASRS) (30.2% overall; range = 0.3%–64.5%)”
Quote in the paperNot a substantial claim - Findingown data
There was heterogeneity in prevalence ratios across sites (Mantel-Haenszel test p<0.01).
“Mantel-Haenszel test of homogeneity of prevalence ratios across sites p<0.01, indicating heterogeneity in prevalence ratios across sites.”
Quote in the paperNot a substantial claim - Findingown data
Overall ASD prevalence per 1,000 among children aged 8 years was higher for A/PI (38.2), Black (36.6), Hispanic (33.0), and Multiracial (31.9) children than for White children (27.7).
“| Total | 49.2 (48.1–50.3) | 14.3 (13.7–15.0) | 3.4 (3.3–3.6)** | 38.2 (35.4–41.2) | 36.6 (35.1–38.1) | 33.0 (31.7–34.4) | 31.9 (29.0–35.1) | 27.7 (26.8–28.7) | 1.4 (1.3–1.5)** | 1.3 (1.3–1.4)** | 1.2 (1.1–1.3)** | 1.2 (1.0–1.3)** |”
Quote in the paperSubstantial claim - Findingown data
Overall, 66.5% of children aged 8 years with ASD had any documented autism test.
“Overall, 66.5% of children aged 8 years with ASD had any documented autism test.”
Quote in the paperNot a substantial claim - Findingown data
Utah was the only site in which another racial or ethnic group had lower ASD prevalence than White children (multiracial compared with White).
“Utah was the only site in which another racial or ethnic group had lower ASD prevalence than White children (multiracial compared with White).”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Findingown data
The overall percentage of children with ASD who had a documented autism special education eligibility was 67.3% (range 38.3% in Texas [Laredo] to 90.2% in Puerto Rico).
“The overall percentage of children with ASD who had a documented autism special education eligibility was 67.3% (range = 38.3% in Texas [Laredo] to 90.2% in Puerto Rico)”
Quote in the paperNot a substantial claim - Findingown data
Overall prevalence among children aged 4 years was lower than among children aged 8 years in seven sites (Arizona, Arkansas, Georgia, Indiana, Minnesota, Missouri, and Utah).
“Overall prevalence among children aged 4 years was lower than among children aged 8 years in seven sites (Arizona, Arkansas, Georgia, Indiana, Minnesota, Missouri, and Utah)”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 4 years with ASD, 69.1% had an ASD test documented.
“Compared with children aged 8 years with ASD, a similar proportion of children aged 4 years with ASD had an ASD test documented in their records (69.1%)”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, 39.6% had a documented ADOS test (range 10.6%-63.9%).
“The most common autism tests were the Autism Diagnostic Observation Schedule (ADOS) (39.6% overall; range = 10.6%–63.9%)”
Quote in the paperNot a substantial claim - Findingown data
69.9% of children with ASD had at least two of the three types of ASD identification documented in their records.
“A majority (69.9%) of children with ASD had at least two of the three types of ASD identification documented in their records”
Quote in the paperNot a substantial claim - Findingown data
The order of autism tests by frequency differed between children aged 4 years and children aged 8 years with ASD.
“though the order of tests by frequency was different”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD who had data on cognitive ability, 36.1% were classified in the average or higher range (IQ >85).
“36.1% were classified in the average or higher range (IQ >85)”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD, 2.7% had a documented ADI-R test (range 0%-11.6%).
“Autism Diagnostic Interview-Revised (ADI-R) (2.7% overall; range = 0%–11.6%)”
Quote in the paperNot a substantial claim - Findingown data
Data on cognitive ability were available for 5,292 (61.4%) children aged 8 years with ASD (range 21.3% in Texas [Laredo] to 90.2% in Arkansas).
“Data on cognitive ability were available for 5,292 (61.4%) children aged 8 years with ASD (range = 21.3% in Texas [Laredo] to 90.2% in Arkansas)”
Quote in the paperNot a substantial claim - Findingown data
Black children were less likely to have data on cognitive ability (59.3%) than multiracial children (66.4%) and White children (63.1%).
“Black children were less likely to have data on cognitive ability (59.3%) than multiracial children (66.4%) and White children (63.1%).”
Quote in the paperNot a substantial claim - Findingown data
63.7% of children aged 8 years had ≥1 IEP available in their records.
“Of children with ≥1 IEP available in their records (63.7% of children aged 8 years)”
Quote in the paperNot a substantial claim - Findingown data
The proportion of children aged 4 years with ASD with an ASD test documented was similar to that among children aged 8 years.
“Compared with children aged 8 years with ASD, a similar proportion of children aged 4 years with ASD had an ASD test documented in their records (69.1%)”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 8 years with ASD who had data on cognitive ability, 39.6% were classified as having intellectual disability (IQ ≤70).
“Among children aged 8 years with ASD who had data on cognitive ability, 39.6% were classified as having intellectual disability (IQ ≤70) at their most recent test or examination”
Quote in the paperNot a substantial claim - Findingown data
34.7% of children with ASD had all three types of ASD identification documented in their records.
“and 34.7% had all three types”
Quote in the paperNot a substantial claim - Findingown data
Overall ASD prevalence among children aged 8 years in the 16 ADDM sites in 2022 was 32.2 per 1,000.
“Horizontal line is the overall Autism and Developmental Disabilities Monitoring Network prevalence of 32.2 per 1,000 children aged 8 years.”
Quote in the paperSubstantial claim - Interpretationown data
The increased early identification is consistent with historical patterns.
“Identification by age 48 months was higher among children born in 2018 compared with children born in 2014, suggesting increased early identification consistent with historical patterns.”
Quote in the paperNot a substantial claim - Premisecitation
ASD prevalence increased from one in 150 in 2000 to one in 36 in 2020.
“Prevalence increased from one in 150 in 2000 (5) to one in 36 in 2020 (6), and demographic patterns in ASD identification changed.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators, 2007, Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2000., MMWR Surveill Summ
Not checked in the free run.
- cites [6] Maenner, 2023, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- Premisecitation
In 2020, higher ASD prevalence was observed for the first time among historically underserved groups including non-Hispanic Black and Hispanic children.
“In 2020, higher ASD prevalence was observed for the first time among historically underserved groups including non-Hispanic Black and Hispanic children, and an association between ASD prevalence and SES (measured by median household income [MHI] tertile) was not present in the majority of sites (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Maenner, 2023, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- Premisecitation
In 2020, an association between ASD prevalence and socioeconomic status measured by median household income tertile was not present in the majority of sites.
“In 2020, higher ASD prevalence was observed for the first time among historically underserved groups including non-Hispanic Black and Hispanic children, and an association between ASD prevalence and SES (measured by median household income [MHI] tertile) was not present in the majority of sites (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Maenner, 2023, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- Interpretationown data
Prevalence of ASD among children aged 8 years was higher in 2022 than previous years.
“Prevalence of ASD among children aged 8 years was higher in 2022 than previous years.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Interpretationown data
In 2022, findings from the 16 diverse sites in the ADDM Network highlighted substantial differences in community practices for identifying ASD.
“In 2022, findings from the 16 diverse sites in the ADDM Network highlighted substantial differences in community practices for identifying ASD.”
Quote in the paperSubstantial claim - Interpretationreasoning
Differences in the prevalence of children identified with ASD across communities might be due to differences in availability of services for early detection and evaluation and diagnostic practices.
“Differences in the prevalence of children identified with ASD across communities might be due to differences in availability of services for early detection and evaluation and diagnostic practices.”
Quote in the paperSubstantial claim- Rests on an assumption: Research has not demonstrated that living in certain communities puts children at greater risk for developing ASD.
- Premisecitation
California has had the highest prevalence among children aged 4 years and 8 years since joining the ADDM Network in 2018.
“California has had the highest prevalence among children aged 4 years and 8 years since joining the ADDM Network in 2018 (6,10,11,13)”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [6] Maenner, 2023, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- cites [10] Shaw, 2021, Early identification of autism spectrum disorder among children aged 4 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- cites [11] Shaw, 2023, Early identification of autism spectrum disorder among children aged 4 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- cites [13] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Study design and conductreasoning
Indiana was not included in analyses or visualizations of elements of the ASD case definition because information about ASD diagnostic statements was not available.
“Therefore, Indiana was not included in analyses or visualizations of elements of the ASD case definition because information about ASD diagnostic statements was not available.”
Quote in the paperNot a substantial claim - Study design and conductcitation
Surveillance was conducted using the same surveillance methods and case definitions used in 2018 and 2020.
“Surveillance was conducted using the same surveillance methods and case definitions used in 2018 and 2020 (6,13).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Maenner, 2023, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
- cites [13] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Interpretationreasoning
Higher ASD identification in the younger cohort in Puerto Rico could reflect dedicated joint efforts since 2017 by the Puerto Rico Title V Children with Special Health Care Needs Program and the Puerto Rico "Learn the Signs. Act Early." Ambassador to decrease the age when children at risk for ASD receive their first diagnostic evaluation.
“Higher ASD identification in the younger cohort could reflect dedicated joint efforts since 2017 by the Puerto Rico Title V Children with Special Health Care Needs Program and the Puerto Rico “Learn the Signs. Act Early.” Ambassador to decrease the age when children at risk for ASD receive their first diagnostic evaluation.”
Quote in the paperNot a substantial claim
- May combine two claims. 25
- Classified as probably not a substantial claim. 13
May combine two claims.
Findingown dataIntellectual disability was present among 52.8% of Black, 50.0% of AI/AN, 43.9% of A/PI, 38.8% of Hispanic, 32.7% of White, and 31.2% of multiracial children with ASD.
“Intellectual disability was present among 52.8% of Black, 50.0% of AI/AN, 43.9% of A/PI, 38.8% of Hispanic, 32.7% of White, and 31.2% of multiracial children with ASD.”
Quote in the paperNot a substantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
May combine two claims.
Findingown dataOf the 8,613 children aged 8 years with ASD, 68.4% had a documented diagnostic statement of ASD, 67.3% had documented autism special education eligibility, and 68.9% had a documented ASD ICD-9 or ICD-10 code.
“Of these 8,613 children, 68.4% had a documented diagnostic statement of ASD, 67.3% had a documented autism special education eligibility, and 68.9% had a documented ASD ICD-9 or ICD-10 code.”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
May combine two claims.
Findingown dataVariability was observed in where children were identified (health or education setting), the frequency of cognitive and IQ testing, the proportion of children with IQ ≤70, and the use of ASD diagnostic tests.
“Variability was also observed in where children were identified (i.e., in a health or education setting), the frequency of cognitive and IQ testing, the proportion of children with IQ ≤70, and the use of ASD diagnostic tests.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPrevalence of suspected ASD was 3.1 per 1,000 children aged 4 years, which translated to one child suspected of having ASD for every 10 children identified with ASD among children aged 4 years.
“Prevalence of suspected ASD was 3.1 per 1,000 children aged 4 years, which translated to one child suspected of having ASD for every 10 children identified with ASD among children aged 4 years”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong children aged 4 years with ASD, the most common documented autism test was CARS (38.0%), followed by ADOS (31.7%), ASRS (21.1%), TELE-ASD-PEDS (8.7%), SRS (8.1%), GARS (6.2%), and ADI-R (3.8%).
“The most common autism test documented among children aged 4 years with ASD was the CARS (38.0%), followed by the ADOS (31.7%), ASRS (21.1%), TELE-ASD-PEDS (8.7%), SRS (8.1%), GARS (6.2%), and ADI-R (3.8%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe pattern of more evaluations and ASD identification among children born in 2018 resumed by June 2020 and varied by site.
“The pattern of more evaluations and ASD identification among children born in 2018 resumed by June 2020 (Figure 5) and varied by site”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe Georgia site was the only site that met the threshold for statistical precision for AI/AN prevalence; its AI/AN prevalence per 1,000 was 204.5 (95% CI 111.5-345.0).
“The Georgia site was the only site that met the threshold for statistical precision for AI/AN prevalence; the site-specific prevalence per 1,000 was 204.5 (111.5–345.0).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere were significant differences for Pearson chi-square tests for proportion of Black children with IQ ≤70 among children with ASD versus A/PI, Hispanic, multiracial, or White (each comparison p<0.001); A/PI children with IQ ≤70 versus multiracial or White (each comparison p<0.001); Hispanic children with IQ ≤70 versus multiracial (p=0.02) or White children (p<0.001).
“Significant differences for Pearson chi-square tests for proportion of Black children with IQ ≤70 among children with ASD versus A/PI, Hispanic, multiracial, or White (each comparison p<0.001); A/PI children with IQ ≤70 among children with ASD versus multiracial or White (each comparison p<0.001); Hispanic children with IQ ≤70 among children with ASD versus multiracial (p = 0.02) or White children”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong children aged 8 years with ASD in 2022, prevalence per 1,000 was 49.2 for males and 14.3 for females, with a male-to-female prevalence ratio of 3.4.
“| Total | 49.2 (48.1–50.3) | 14.3 (13.7–15.0) | 3.4 (3.3–3.6)** |”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSimilar percentages of girls and boys with ASD had data on cognitive ability (61.0% and 61.7%, respectively).
“Similar percentages of girls and boys with ASD had data on cognitive ability (61.0 and 61.7%, respectively).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThis pattern was consistent at most (13 of 16) sites, ranging from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico.
“This pattern was consistent at most (13 of 16) sites, ranging from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong children with ≥1 IEP available, the top five eligibility categories were autism (77.7%), speech or language impairment (24.7%), health, physical, or other disability (7.9%), developmental delay (6.9%), and intellectual disability (3.6%).
“the top five eligibility categories were autism (77.7% of children); speech or language impairment (24.7%); health, physical, or other disability (7.9%); developmental delay (6.9%); and intellectual disability (3.6%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataLower neighborhood MHI was associated with higher ASD prevalence for five sites (New Jersey, Tennessee, Texas [Laredo], Utah, and Wisconsin) and overall, although the overall trend was not monotonic.
“lower neighborhood MHI was associated with higher ASD prevalence for five sites (New Jersey, Tennessee, Texas [Laredo], Utah, and Wisconsin) and overall (although the overall trend was not monotonic)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataASD prevalence per 1,000 children aged 4 years in the 16 sites combined was 29.3, which was 0.9 times the overall prevalence among children aged 8 years in 2022.
“ASD prevalence per 1,000 children aged 4 years in the 16 sites combined was 29.3, which was 0.9 times the overall prevalence among children aged 8 years in 2022”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe median age of most recent cognitive test was 67 months overall and varied by site (range 45 months in Texas [Austin] to 85 months in Puerto Rico).
“The median age of most recent cognitive test was 67 months overall and varied by site (range = 45 months in Texas [Austin] to 85 months in Puerto Rico)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHigher social vulnerability was observed with higher ASD prevalence at five sites (Maryland, New Jersey, Tennessee, Utah, and Wisconsin) and overall, although overall, Maryland and Tennessee trends were not monotonic.
“higher social vulnerability was observed with higher ASD prevalence at five sites (Maryland, New Jersey, Tennessee, Utah, and Wisconsin) and overall (although overall, Maryland and Tennessee trends were not monotonic)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAI/AN-to-White prevalence ratios were significant for Georgia (8.5 [95% CI 4.7-15.5]) and overall (1.4 [95% CI 1.0-1.9]).
“AI/AN-to-White ratios were significant for Georgia (8.5 [95% CI = 4.7–15.5]) and overall (1.4 [95% CI = 1.0–1.9]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong the 11 sites that conducted ASD surveillance in both 2020 and 2022, prevalence was higher in 2022 than in 2020 at nine sites (from 14.0% to 36.7% higher) and overall (22.2% higher; absolute difference of 6.1 more children with ASD per 1,000 children aged 8 years).
“Among the 11 sites, prevalence was higher in 2022 than in 2020 at nine (from 14.0% to 36.7% higher) and overall (22.2% higher [absolute difference of 6.1 more children with ASD per 1,000 children aged 8 years]).”
Quote in the paperSubstantial claim- Rests on an assumption: The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
- Rests on an assumption: Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
May combine two claims.
FindingreasoningPuerto Rico was the site with second-highest prevalence among children aged 4 years, but prevalence among children aged 8 years in Puerto Rico was below the ADDM Network average.
“Puerto Rico was the site with second-highest prevalence among children aged 4 years, but prevalence among children aged 8 years in Puerto Rico was below the ADDM Network average.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe American Academy of Pediatrics recommends that pediatric care providers screen all children for ASD at ages 18 and 24 months.
“the American Academy of Pediatrics recommends that pediatric care providers screen all children for ASD at ages 18 and 24 months (2,3).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Hyman, 2020, Identification, evaluation, and management of children with autism spectrum disorder., Pediatrics source
Not checked in the free run.
- cites [3] Lipkin, 2020, Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening., Pediatrics source
Not checked in the free run.
May combine two claims.
PremisecitationBefore 2016, the highest ASD prevalence was observed among White children and in children from neighborhoods with higher socioeconomic status.
“Before 2016, the highest ASD prevalence was observed among White children and in children from neighborhoods with higher socioeconomic status (SES) (7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Durkin, 2017, Autism spectrum disorder among US children (2002–2010): socioeconomic, racial, and ethnic disparities., Am J Public Health source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough prevalence has been lower among children aged 4 years than aged 8 years in each reporting year, comparing cumulative incidence of identification by age 48 months has consistently indicated higher rates of ASD identification in younger cohorts.
“Although prevalence has been lower among children aged 4 years than aged 8 years in each reporting year, comparing cumulative incidence of identification by age 48 months has consistently indicated higher rates of ASD identification in younger cohorts (i.e., children born more recently) (9–11).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [10] Shaw, 2021, Early identification of autism spectrum disorder among children aged 4 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- cites [11] Shaw, 2023, Early identification of autism spectrum disorder among children aged 4 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA report that presented data collected in 2020 found interruptions to early identification during the onset of the COVID-19 pandemic.
“A report that presented data collected in 2020 found interruptions to early identification during the onset of the COVID-19 pandemic (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Shaw, 2023, Early identification of autism spectrum disorder among children aged 4 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataRecord abstraction was completed for 15 of the 16 sites for 8,613 children aged 8 years who met the ASD case definition.
“Record abstraction was completed for 15 of the 16 sites for 8,613 children aged 8 years who met the ASD case definition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisecitationEarly identification of ASD can help children receive services and supports they might need for their development and to improve long-term outcomes.
“Early identification of ASD can help children receive services and supports they might need for their development and to improve long-term outcomes (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Zwaigenbaum, 2015, Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research., Pediatrics source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningA Bayesian hierarchical modelling approach and random-effects restricted maximum likelihood method were used to calculate overall prevalence and measures of uncertainty among children aged 8 years to better account for the wide range in prevalence across sites.
“A Bayesian hierarchical modelling approach and random-effects restricted maximum likelihood method were also used to calculate overall prevalence and measures of uncertainty (95% Bayesian credible intervals and 95% CIs, respectively) among children aged 8 years to better account for the wide range in prevalence across sites; full details are available (Supplementary Methods 2, https://stacks.cdc.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisenone givenCalifornia has a local initiative (the Get SET Early model).
“and has a local initiative (the Get SET Early model).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThirteen sites had data agreements with education sources covering 100% of their study areas; three sites had agreements with education data sources covering less than 100% (Georgia 97.3%, Missouri 68.0%, and Texas [Laredo] 99.7%).
“Thirteen sites had data agreements in place with education sources covering 100% of their study areas; three sites had agreements with education data sources covering <100% (Georgia [97.3%], Missouri [68.0%], and Texas [Laredo] [99.7%]).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataIndiana is included in analyses of prevalence by demographic characteristics, MHI, and SVI but excluded from other analyses that required data from record abstraction.
“Because Indiana did not have data available from record abstraction, Indiana is included in analyses of prevalence (by demographic characteristics, MHI, and SVI) but excluded from other analyses that required data from record abstraction (e.g., co-occurring intellectual disability or presence of evaluation or diagnosis or age at evaluation or diagnosis).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCalifornia has regional centers throughout the state that provide evaluations and service coordination for persons with disabilities and their families.
“In addition, California has regional centers throughout the state that provide evaluations and service coordination for persons with disabilities and their families (https://www.dds.ca.gov).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites https://www.dds.ca.gov
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningVariability in identification practices could affect receipt of services and suggests opportunities to implement successful identification strategies to ensure children in all communities receive the diagnostic and care services they need.
“Variability in identification practices could affect receipt of services and suggests opportunities to implement successful identification strategies to ensure children in all communities receive the diagnostic and care services they need.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPrevalence estimates with a relative standard error of 30% or greater were suppressed because of limited statistical precision.
“Prevalence estimates with a relative standard error ≥30% were suppressed because of limited statistical precision.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll sites participating in 2022 had access to health and education records.
“All sites participating in 2022 had access to health and education records (Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationAs part of the Get SET Early initiative, hundreds of local pediatricians have been trained to screen and refer children for assessment as early as possible, which could result in higher identification of ASD, especially at early ages.
“As part of the initiative, hundreds of local pediatricians have been trained to screen and refer children for assessment as early as possible, which could result in higher identification of ASD, especially at early ages (17).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Pierce, 2021, Get SET Early to identify and treatment refer autism spectrum disorder at 1 year and discover factors that influence early diagnosis., J Pediatr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAnother reason for differences in prevalence could be whether children have insurance coverage or meet eligibility criteria for access to early intervention services.
“Another reason for differences in prevalence could be whether children have insurance coverage or meet eligibility criteria for access to early intervention services.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPennsylvania, the site with second highest prevalence among children aged 8 years, has state Medicaid policy that includes children with physical, developmental, mental health, or intellectual disabilities regardless of parents' income.
“Pennsylvania, the site with second highest prevalence among children aged 8 years, has state Medicaid policy that includes children with physical, developmental, mental health, or intellectual disabilities regardless of parents’ income (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Commonwealth of Pennsylvania, Department of Human Services. Medicaid for children with special needs. Harrisburg, PA: Commonwealth of Pennsylvania, Department of Human Services; 2024. https://www.pa.gov/agencies/dhs/resources/medicaid/medicaid-children-special-needs-ph95.html
Not checked in the free run.
The paper relies on this without support.
The surveillance ASD case definition accurately identifies children with ASD in the surveillance population.
“children aged 8 years (born in 2014) or aged 4 years (born in 2018) met the surveillance ASD case definition if they lived in the surveillance area at any time in 2022 and they received 1) an ASD diagnostic statement in a comprehensive developmental evaluation, 2) autism special education eligibility, or 3) an ASD ICD-9 code in the 299 range or ICD-10 code of F84.0, F84.3, F84.5, F84.8, or F84.9.”
The paper relies on this without support.
Children with ASD who are not captured by the available health and education records are negligible or do not substantially bias prevalence estimates.
“All sites participating in 2022 had access to health and education records (Table 1).”
The authors state this as an assumption.
The methodology assumes that all Puerto Rico residents are Hispanic.
“This methodology assumes that all Puerto Rico residents are Hispanic.”
The paper relies on this without support.
Research has not demonstrated that living in certain communities puts children at greater risk for developing ASD.
“Research has not demonstrated that living in certain communities puts children at greater risk for developing ASD.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Maximum identification increase is misstated as 300%
MinorThe reported maximum ratio of 3.1 times corresponds to 210% higher, not 300% higher. A 300% increase would be four times the earlier rate.
“In 2022, across the 13 sites with higher cumulative incidence of identification by age 48 months among children aged 4 years (born in 2018) compared with children aged 8 years (born in 2014), identification was 40%–300% higher in the younger group.”
“This pattern was consistent at most (13 of 16) sites, ranging from 1.4 times as high in Arizona and Georgia to 3.1 times as high in Puerto Rico.”
Conflicting percentages for children with all three ASD identification elements
MinorThe abstract reports 34.6%, whereas the Results section reports 34.7% for the same group of children across the 15 sites.
“All three elements of the ASD case definition were present for 34.6% of children aged 8 years with ASD.”
“A majority (69.9%) of children with ASD had at least two of the three types of ASD identification documented in their records and 34.7% had all three types (Figure 3).”
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476 · see citing works
Maenner, M. J., Warren, Z., Williams, A. R., Amoakohene, E., Bakian, A. V., Bilder, D. A., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., et al. (2023) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7202a1 · Cited by 2,706 · see citing works
Self-citationMaenner, M. J., Shaw, K. A., Bakian, A. V., Bilder, D. A., Durkin, M. S., Esler, A., Furnier, S. M., Hallas, L., Hall-Lande, J., Hudson, A., et al. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7011a1 · Cited by 1,818 · cited 4× · see citing works
“For example, California has had the highest prevalence among children aged 4 years and 8 years since joining the ADDM Network in 2018 ( 6 , 10,11,13 ) and has a local initiative (the Get SET Early model).”
InfluentialSelf-citationIdentification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,548 · see citing works
Zwaigenbaum, L., Bauman, M. L., Choueiri, R., Kasari, C., Carter, A., Granpeesheh, D., Mailloux, Z., Smith Roley, S., Wagner, S., Fein, D., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-3667e · Cited by 856 · see citing works
Self-citationLipkin, P. H., Macias, M. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Norwood, K. W., Brei, T. J., Davidson, L. F., Davis, B. E., Ellerbeck, K. A., Houtrow, A. J., Hyman, S. L., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3449 · Cited by 676 · see citing works
Christensen, D., Bilder, D. A., Zahorodny, W. M., Pettygrove, S. D., Durkin, M. S., Fitzgerald, R. T., Rice, C. E., Kurzius‐Spencer, M., Baio, J., & Yeargin‐Allsopp, M. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000235 · Cited by 389 · see citing works
Self-citationDurkin, M. S., Maenner, M. J., Baio, J., Christensen, D., Daniels, J., Fitzgerald, R., Imm, P., Lee, L.-C., Schieve, L. A., Van Naarden Braun, K., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304032 · Cited by 347 · see citing works
Self-citationPierce, K., Gazestani, V. H., Bacon, E., Barnes, C. C., Cha, D., Nalabolu, S., Lopez, L., Moore, A., Pence-Stophaeros, S., & Courchesne, E. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.0624 · Cited by 333 · see citing works
Self-citationShaw, K. A., Maenner, M. J., Baio, J., EdS1, Washington, A., Christensen, D. L., Wiggins, L. D., Pettygrove, S., Andrews, J. G., White, T., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6903a1 · Cited by 286 · see citing works
Self-citationEarly neurodevelopmental outcomes of extremely preterm infants
Rogers, E. E., & Hintz, S. R. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2016.09.002 · Cited by 248 · see citing works
Roman-Urrestarazu, A., van Kessel, R., Allison, C., Matthews, F. E., Brayne, C., & Baron-Cohen, S. (2021) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.0054 · Cited by 242 · see citing works
Shaw, K. A., Bilder, D. A., McArthur, D., Williams, A. R., Amoakohene, E., Bakian, A. V., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., et al. (2023) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7201a1 · Cited by 223 · see citing works
Self-citationPublic Health Implications of Very Preterm Birth
Barfield, W. D. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2018.05.007 · Cited by 203 · see citing works
Shaw, K. A., Maenner, M. J., Bakian, A. V., Bilder, D. A., Durkin, M. S., Furnier, S. M., Hughes, M. M., Patrick, M., Pierce, K., Salinas, A., et al. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7010a1 · Cited by 165 · see citing works
Self-citationEnvironmental Inequality: The Social Causes and Consequences of Lead Exposure
Muller, C. D., Sampson, R. J., & Winter, A. S. (2018) · Annual Review of Sociology · doi:10.1146/annurev-soc-073117-041222 · Cited by 159 · see citing works
Fuller, E. A., Oliver, K., Vejnoska, S., & Rogers, S. J. (2020) · Brain Sciences · doi:10.3390/brainsci10060368 · Cited by 158 · see citing works
The role of social determinants in explaining racial/ethnic disparities in perinatal outcomes
Lorch, S. A., & Enlow, E. (2015) · Pediatric Research · doi:10.1038/pr.2015.199 · Cited by 154 · see citing works
Johnson, L. W., & Diaz, I. (2023) · Brain Sciences · doi:10.3390/brainsci13050707 · Cited by 88 · see citing works
Patrick, M. E., Shaw, K. A., Dietz, P. M., Baio, J., Yeargin-Allsopp, M., Bilder, D. A., Kirby, R. S., Hall-Lande, J. A., Harrington, R. A., Lee, L.-C., et al. (2021) · Disability and Health Journal · doi:10.1016/j.dhjo.2020.101023 · Cited by 70 · see citing works
Self-citationShaw, K. A., McArthur, D., Hughes, M. M., Bakian, A. V., Lee, L., Pettygrove, S. D., & Maenner, M. J. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.11.019 · Cited by 68 · see citing works
Self-citationPierce, K., Gazestani, V., Bacon, E., Courchesne, E., Cheng, A., Barnes, C. C., Nalabolu, S., Cha, D., Arias, S., Lopez, L., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.04.041 · Cited by 66 · cited 1× · see citing works
“As part of the initiative, hundreds of local pediatricians have been trained to screen and refer children for assessment as early as possible, which could result in higher identification of ASD, especially at early ages ( 17 ).”
Self-citationSocioeconomic Status and Pediatric Neurologic Disorders: Current Evidence
Durkin, M. S., & Yeargin‐Allsopp, M. (2018) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2018.03.003 · Cited by 63 · see citing works
Self-citationShifts in the distribution of births by gestational age, United States, 2014-2022
Martin, J. A., & Osterman, M. J. K. (2023) · doi:10.15620/cdc:135610 · Cited by 50 · see citing works
The social patterning of autism diagnoses reversed in California between 1992 and 2018.
Winter, A. S., Fountain, C., Cheslack-Postava, K., & Bearman, P. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015762117 · Cited by 33 · see citing works
Health Conditions, Education Services, and Transition Planning for Adolescents With Autism
Hughes, M. M., Pas, E. T., Durkin, M. S., DaWalt, L. S., Bilder, D. A., Bakian, A. V., Amoakohene, E., Shaw, K. A., Patrick, M., Salinas, A., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2023-063672 · Cited by 12 · see citing works
Self-citationStatewide county-level autism spectrum disorder prevalence estimates—seven U.S. states, 2018
Shaw, K. A., Williams, S., Hughes, M. M., Warren, Z. E., Bakian, A. V., Durkin, M. S., Esler, A., Hall‐Lande, J., Salinas, A., Vehorn, A. C., et al. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.01.010 · Cited by 8 · see citing works
Self-citationPatrick, M., Williams, A. R., Shaw, K. A., Durkin, M. S., Hall‐Lande, J., Vehorn, A. C., & Hughes, M. M. (2025) · Annals of Epidemiology · doi:10.1016/j.annepidem.2025.02.014 · Cited by 7 · see citing works
Self-citation(2024) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7315a5 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Behrman RE, Butler AS, eds. Sociodemographic and community factors contributing to preterm birth [Chapter 4]. In: Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press (US); 2007:124–47.
Cited by
Sorted by citations
Sohn, J.-S., Lee, E., Kim, J., Oh, H.-K., & Kim, E. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1628216 · Cited by 40 · see citing works
Fyfe, C., Winell, H., Dougherty, J. D., Gutmann, D. H., Kolevzon, A. L., Marrus, N. M., Tedroff, K., Turner, T. N., Weiss, L. A., Yip, B. H. K., et al. (2026) · BMJ · doi:10.1136/bmj-2025-084164 · Cited by 36 · see citing works
Mechanistic Links Between Gut Dysbiosis, Insulin Resistance, and Autism Spectrum Disorder
Guevara‐Ramírez, P., Tamayo‐Trujillo, R., Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Paz‐Cruz, E., & Zambrano, A. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136537 · Cited by 20 · see citing works
PET Imaging in Psychiatric Disorders.
Ferrando, R., Hernandes, D., Ghini, B. G., & Coutinho, A. (2025) · Seminars in nuclear medicine · doi:10.1053/j.semnuclmed.2025.06.004 · Cited by 16 · see citing works
Ayoub, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136483 · Cited by 15 · see citing works
Microglial involvement in autism spectrum disorder: insights from human data and iPSC models
Michels, S., Mali, A. S., Jäntti, H., Rezaie, M., & Malm, T. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106071 · Cited by 16 · see citing works
Challenges in translating AI-driven ASD/ADHD diagnosis: A methodological systematic review
Rasool, A., Ahmad, F., Bunterngchit, C., & Aslam, S. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106417 · Cited by 19 · see citing works
Autism Spectrum Disorder: The Cerebellum, Genes, and Pathways
D’Mello, S. R. (2025) · Neurology International · doi:10.3390/neurolint17100173 · Cited by 14 · see citing works
Autism: Trump links condition to Tylenol and touts leucovorin as “first” US therapeutic
Looi, M.-K., & Bowie, K. (2025) · BMJ · doi:10.1136/bmj.r2004 · Cited by 14 · see citing works
Panjabud, P., Kanlayaprasit, S., Thongkorn, S., Songsritaya, K., Lertpeerapan, P., Kasitipradit, K., Jantheang, T., Sarobol, S., Saeliw, T., Hu, V. W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09909-9 · Cited by 13 · see citing works
Han, W., Yang, X., Li, X., Wang, J., Liu, J., & Pang, W. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106235 · Cited by 13 · see citing works
Human neurons are susceptible to the internalization of small-sized nanoplastics
Ito, T., Ikuno, Y., Udagawa, O., Tanaka, K., Kurokawa, Y., Kakeyama, M., & Maekawa, F. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104776 · Cited by 12 · see citing works
The autism ‘epidemic’: misinterpretation, misinformation and conspiracy
Fombonne, E. J. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01316-8 · Cited by 14 · see citing works
Zaleski, A. L., Craig, K. J. T., Khan, R., Waber, R., Xin, W., Powers, M., Ramey, U., Verbrugge, D. J., & Fernandez-Turner, D. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13296-2 · Cited by 11 · see citing works
An analysis of the real world performance of an artificial intelligence based autism diagnostic
Salomon, C., Heinz, K., Aronson-Ramos, J., & Wall, D. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-15575-8 · Cited by 11 · see citing works
Yadav, A., Tadas, M., Kale, M. B., Wankhede, N. L., Umekar, M. J., Kotagale, N. R., & Taksande, B. G. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114989 · Cited by 11 · see citing works
Burrows, C. A., Sung, S., Zheng, S., Young, G. S., Charman, T., Klaiman, C., Klin, A. J., Marrus, N. M., Ozonoff, S. J., Piven, J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.25887 · Cited by 9 · see citing works
Self-citationChen, W., Wang, X., Zhu, R., Gao, W., Tao, L., Yang, R., Wei, Q., Zhang, Y., Gong, Y., Zhong, H., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102516 · Cited by 12 · see citing works
Molecular and Genetic Mechanisms in Autism Spectrum Disorder
Pruitt, A., Gupta, A. R., & Hoffman, E. J. (2025) · Annals of Neurology · doi:10.1002/ana.70013 · Cited by 8 · see citing works
Hirose, N., Tashiro, Y., & Takasaki, T. (2025) · Children · doi:10.3390/children12080987 · Cited by 7 · see citing works
Tatom, R. C., & Newbutt, N. A. (2025) · Frontiers in Virtual Reality · doi:10.3389/frvir.2025.1648971 · Cited by 7 · see citing works
Ain, G. (2025) · Frontiers in Education · doi:10.3389/feduc.2025.1647206 · Cited by 10 · see citing works
Lin, D., Shi, Z., Hao, Z., Xie, X., Fang, J., Li, M., Zhang, W., Luo, S., & Xue, A. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1681565 · Cited by 7 · see citing works
Némorin, H., Michelon, C., Peyre, H., Monnier, M., Périés, M., & Baghdadli, A. (2025) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2025.105040 · Cited by 6 · see citing works
Curado, P. R., Mezzatesta, M., Elias, N., Aparici, M., & Mairena, M. Á. (2025) · Journal of Intellectual Disability Research · doi:10.1111/jir.70022 · Cited by 6 · see citing works
Autism spectrum disorder: overdiagnosis or a new pandemic?
Grokoski, K. C., Riesgo, R. D. S., & Gadia, C. A. (2025) · Jornal de Pediatria · doi:10.1016/j.jped.2025.101439 · Cited by 6 · see citing works
Benedetto, G. D., Sorge, G., Sarchiapone, M., & Martino, L. D. (2025) · Nutrients · doi:10.3390/nu17213476 · Cited by 8 · see citing works
Shah, S. M., Madhavan, S. P., Bowden, N., & Nedgungadi, P. (2026) · Research in Autism · doi:10.1016/j.reia.2026.202836 · Cited by 6 · see citing works
Mitochondrial dynamics in neurodevelopment and neurodevelopmental disorders
Sirois, C. L., Lee, J., Chambers, A. L., & Zhao, X. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01031-7 · Cited by 6 · see citing works
Straub, L., Hernández–Dı́az, S., Bateman, B. T., Zhu, Y., Mogun, H., Wisner, K. L., Gray, K. J., Lester, B. M., McDougle, C. J., Pennell, P. B., et al. (2026) · BMJ · doi:10.1136/bmj-2025-085725 · Cited by 6 · see citing works
Zhang, X., Xue, H., Zhu, C., Ji, C., Li, Y. M., & Liu, W. T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1829127 · Cited by 6 · see citing works
Stuefer, A., Colombo, G., Gini, S., Sastre-Yagüe, D., Coletta, L., Rocchi, F., Aldrighetti, M., D’Epifanio, B., Como, G., Balasco, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.07.674483 · Cited by 6 · see citing works
Xu, Y., Chen, F., Mirza, M. P., & Magaña, S. (2025) · Journal of Child and Family Studies · doi:10.1007/s10826-025-03102-2 · Cited by 6 · see citing works
Self-citationMaking America Healthy Again: Remedies for Robert F. Kennedy Jr.'s Campaign against Chronic Disease
Gostin, L. O., Finch, A., & Lurie, P. G. (2025) · The Hastings Center Report · doi:10.1002/hast.5020 · Cited by 5 · see citing works
Lertpeerapan, P., Kanlayaprasit, S., Thongkorn, S., Kasitipradit, K., Panjabud, P., Songsritaya, K., Jantheang, T., Morita, M., Akaike, T., Hu, V. W., et al. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00744-1 · Cited by 5 · see citing works
Ferina, J., Dando, E., Anderson, C., Foster, J., Lantz, J. F., Hamlin, T., & Hahn, J. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15100453 · Cited by 6 · see citing works
Wang, J., Zhou, X., Ma, Z., Liu, L., Zhou, Q., Wen, J.-W., Wen, J.-H., Su, H., Zhang, Y., & Xia, X. (2025) · Toxics · doi:10.3390/toxics13100833 · Cited by 5 · see citing works
Song, X., Hou, Y., Lei, Z., & Zhou, S. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1632555 · Cited by 6 · see citing works
Gullapalli, S., Baldado, L., Szobody, M. W., Murambadoro, A. K., Valdez, K. G., Bellamkonda, A., Gonzalez, D., Ghumman, U., Anand, N., Potter–Baker, K. A., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107187 · Cited by 5 · see citing works
Wang, M., Liang, Z., Zhuang, H., Cao, X., Ma, G., Sun, Y., Yan, X., Ran, X., Guan, H., & Shen, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05567-0 · Cited by 5 · see citing works
Varia, J. C., Herbert, M. R., & Hooker, B. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05589-8 · Cited by 7 · see citing works
O’Sharkey, K., Mitra, S., Chow, T., Goodrich, A. J., Conlon, K. C., Nuño, M., Bennett, D. H., Raffuse, S. M., Astaneh, M., Zhao, Y., et al. (2026) · Environment International · doi:10.1016/j.envint.2026.110131 · Cited by 5 · see citing works
Eccles, J., Weir, E. M., Santhouse, A. M., & Brugha, T. S. (2026) · BMJ · doi:10.1136/bmj.r2648 · Cited by 5 · see citing works
The relationship between autistic camouflaging and mental health: a scoping review
Hodge, E. K., & Meltzoff, K. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1701615 · Cited by 5 · see citing works
Autism is on the rise: what’s really behind the increase?
Pearson, H. (2025) · Nature · doi:10.1038/d41586-025-02636-1 · Cited by 5 · see citing works
De Novo Variants Predominate in Autism Spectrum Disorder
Boles, R. G., Bar, O., Boles, P. T., Hill, Z. R., & Frye, R. E. (2025) · Genes · doi:10.3390/genes16091099 · Cited by 5 · see citing works
Montilla, A., & Sanderson, K. A. (2025) · Research in Autism · doi:10.1016/j.reia.2025.202629 · Cited by 4 · see citing works
Kreiser, N., & Segal, O. (2025) · Autism & Developmental Language Impairments · doi:10.1177/23969415251355462 · Cited by 4 · see citing works
The healthcare experiences of middle and older age autistic women in the United Kingdom
Gillions, A., O’Nions, E., Mansour, H., Hoare, S., Mandy, W., & Stott, J. C. H. (2025) · Autism · doi:10.1177/13623613251362265 · Cited by 4 · see citing works
A Longitudinal Transdisciplinary Approach for Autism Spectrum Disorder
Kabarite, A., Ferreira, G. M. M., Pitangueira, J. C., Arimatéa, R. D. S., de Mendonça, R. D. C. R., Marcello, R., Schulz, T., Riesgo, R. D. S., & Castro, K. (2025) · Children · doi:10.3390/children12091272 · Cited by 5 · see citing works
Neurodevelopmental Outcomes of Moderate to Late Preterm Infants: A Population at Risk
Goode, R. H., German, K. R., & Kuo, D. Z. (2025) · NeoReviews · doi:10.1542/neo.26-11-068 · Cited by 4 · see citing works
McDowell, C. N. (2025) · Journal of Family Theory & Review · doi:10.1111/jftr.70031 · Cited by 4 · see citing works
Wu, Y., Chan, S. S. M., Leung, P. W. L., Lo, H., Ho, S. W. S., Mo, F. Y. M., Ho, C. S. W., Shea, C. K., Su, Q., Leung, T. F., et al. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-07133-y · Cited by 5 · see citing works
Warning signs for identifying neurodevelopmental disorders: a systematic literature review
de Araújo, L. A. (2026) · Jornal de Pediatria · doi:10.1016/j.jped.2025.101478 · Cited by 8 · see citing works
Applying biologically anchored subtypes to advance precision medicine in autism spectrum disorder
Choi, T.-Y., Gunawan, A., Seo, D., Park, J., Ahn, E. H., Suh, S. W., Fuccillo, M. V., & Choi, K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107219 · Cited by 5 · see citing works
Quiñones‐Medina, E., Galleguillos, F., Parra, V., Arriagada, G., & Bustos, F. J. (2026) · Autism Research · doi:10.1002/aur.70186 · Cited by 5 · see citing works
Adıgüzel, E., Bağçovan, B., Bozkurt, N. M., Ünal, G., & Waszkiewicz, N. (2026) · Nutrients · doi:10.3390/nu18050777 · Cited by 4 · see citing works
Huaman-Meza, A. J., & Medrano-Sánchez, E. J. (2026) · Buildings · doi:10.3390/buildings16081490 · Cited by 4 · see citing works
Lin, V., Matta, S. M., Dallman, J. E., Hosie, S., Moreau, M., Franks, A. E., Bourgeron, T., & Hill‐Yardin, E. L. (2025) · Autism Research · doi:10.1002/aur.70112 · Cited by 4 · see citing works
Autism-associated SCN2A deficiency disrupts cortico-striatal circuitry in human brain assembloids
Chen, X., Zhang, J., Wu, J., Robinson, M. J., Kothandaraman, H., Yoo, Y.-E., Dopeso‐Reyes, I. G., Buffenoir, T. D., Halurkar, M. S., Yang, H., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.08.031 · Cited by 4 · see citing works
Öner, M., Lenker, K. P., & Durmus, D. (2025) · Building and Environment · doi:10.1016/j.buildenv.2025.113138 · Cited by 3 · see citing works
Parental educational levels association with autism risk in offsprings and their autistic phenotypes
Liu, X., Guo, C., Lyu, L., Liu, H., Yu, J., Huang, Z., Li, Y., Wei, W., Huang, J., Liao, C., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116649 · Cited by 3 · see citing works
Hu, B., Liang, Q., & Jiang, H. (2025) · Frontiers in Child and Adolescent Psychiatry · doi:10.3389/frcha.2025.1647280 · Cited by 3 · see citing works
Greathouse, A. D., Zemantic, P. K., Strong‐Bak, W., Lieneman, C. C., & Hayes, L. B. (2025) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001416 · Cited by 3 · see citing works
Flynn, C. K., Carr, K., Whiteley, P., Nirmalkar, K., Bellinghiere, A., Hahn, J., Liu, H., Arici, H., Hewitson, L. C., Devlin, M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03620-5 · Cited by 3 · see citing works
AutisTikTok: Analyzing top autism hashtags for creator, content, and persistence over time
Karpinsky, M., McFayden, T. C., Waycaster, A., Neal, A. J., & Harrop, C. (2025) · Research in Autism · doi:10.1016/j.reia.2025.202720 · Cited by 3 · see citing works
Identification of autistic Māori in Aotearoa New Zealand: A national cross-sectional study
Tupou, J., Kewene, F., Morrison-Young, I., Wi-Hongi, A., Sporle, A. A., Diamond, T., Theodore, R. F., & Bowden, N. (2025) · Autism · doi:10.1177/13623613251380927 · Cited by 3 · see citing works
Multimodal LLM vs. Human-Measured Features for AI Predictions of Autism in Home Videos
Azizian, P., Honarmand, M., Jaiswal, A., Kline, A., Dunlap, K., Washington, P. Y., & Wall, D. P. (2025) · Algorithms · doi:10.3390/a18110687 · Cited by 3 · see citing works
Amraoui, N., Dali-Sahi, M., Salmi, T., Kachekouche, Y., Harek, Y., Benguella-Benmansour, M., Berrahoui, S., Dib, J., Benosman, C., & Dennouni-Medjati, N. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04833-5 · Cited by 3 · see citing works
A 3-hit metabolic signaling model for the core symptoms of autism spectrum disorder
Naviaux, R. K. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102096 · Cited by 3 · see citing works
Rezaee, K., Javanmardi, T. S., & Heydari, A. M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001376 · Cited by 3 · see citing works
Chen, Y.-N., Zhao, S.-T., Hu, M., Li, W., Yu, J., Ma, M.-J., Tang, L.-Y., Feng, X., Li, J., & Zhang, Y. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03627-9 · Cited by 3 · see citing works
Petreca, V. G., Barros, J. T., & Harding, S. (2025) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903251404481 · Cited by 4 · see citing works
Applying artificial intelligence in neurodevelopmental disorders management and research
Mohamed, S., Ben-Jaafar, A., Frimpong, M., Roy, S., Sanker, V., Nkrumah-Boateng, P. A., Imran, S., Mumeen, A. A., Mohamed, S., & Awuah, W. A. (2026) · European journal of medical research · doi:10.1186/s40001-025-03740-8 · Cited by 5 · see citing works
Knudsen, L. V., Vafaee, M. S., Sheldrick, A. J., & Michel, T. M. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-025-03093-w · Cited by 3 · see citing works
Ahmmad, M. R., Pantazopoulos, H., & Kothiya, S. H. (2026) · Research in Autism · doi:10.1016/j.reia.2026.202826 · Cited by 3 · see citing works
Tovin, M. M., Madden, S. B., Wu, K., & Núñez-Gaunaurd, A. (2026) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2026.2618078 · Cited by 3 · see citing works
A Noisy Signal? Geographic Bias in FAERS Reports Linking Paracetamol to Autism Spectrum Disorder
Yalçın, H. T., Yalçın, N., Allegaert, K., & Erkekoğlu, P. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020902 · Cited by 3 · see citing works
Clarke, E. M., Lord, C., & Bal, V. H. (2026) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.70124 · Cited by 3 · see citing works
Xiong, N., & Yu, Z. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s585060 · Cited by 3 · see citing works
Gut–Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia
Katiraei, P., Frye, R. E., & Theoharides, T. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041768 · Cited by 3 · see citing works
Estrada, J. A. G., Cesare, N., Barger, K., Sisson, E., Cole, M. B., Holmes, L. G., Parker, S. E., Higgins, A., Ncube, C. N., Rosenberg, S. B., et al. (2026) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70121 · Cited by 3 · see citing works
Yu, Y. Y., Wyman, A., Faulk, C. J., Fulop, L. J., Greenberg, R. L., Benecke, R. M., Steinbeck, L. K., Foy, J., Kim, C., Emory, G. O., et al. (2026) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-026-07253-z · Cited by 3 · see citing works
The proportion of intellectual disability in autism spectrum disorder over two decades
Salkić, A., Tideman, M., Martini, M. I., Larsson, H., Lichtenstein, P., Chang, Z., D'Onofrio, B. M., Brikell, I., Kuja‐Halkola, R., Knez, R., et al. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117246 · Cited by 3 · see citing works
A Review of Neuroproteomics in Neurological Disorders: The Use of Machine Learning and Deep Learning
Mahendran, G., & Kirupaharan, P. (2026) · Sci · doi:10.3390/sci8080207 · Cited by 3 · see citing works
Trump watch: Leaked plan to slash NIH budget in half, CDC contradicts RFK Jr on autism, and more
Looi, M.-K. (2025) · BMJ · doi:10.1136/bmj.r798 · Cited by 3 · see citing works
Dow, M. J., & Wang, T. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22060816 · Cited by 3 · see citing works
Integrating Chatbots: Supporting the College Transition for Autistic Students in Texas
Lee, H., Peña, H., Li, Y.-F., & Cheak-Zamora, N. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06909-6 · Cited by 5 · see citing works
Early biomarker for autism spectrum disorder unveiled – what are we learning?
Rossignol, D. A., & Frye, R. E. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2518143 · Cited by 3 · see citing works
Consensus recommendations for usability and acceptability of mobile health autism screening tools
Tangkilisan, G., Vazquez, L. A. R., Fuchu, P., Sanders, B., Dolata, J. K., Bedrick, S. D., Fombonne, E. J., Broder‐Fingert, S., & Zuckerman, K. E. (2025) · Autism · doi:10.1177/13623613251360276 · Cited by 3 · see citing works
Cianfa, A., Guerrera, S., Fucà, E., Annechini, E., Napoli, V., Vicari, S., & Valeri, G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1638341 · Cited by 3 · see citing works
Arutiunian, V., Opdahl, M., Sullivan, C. A. W., Santhosh, M., Neuhaus, E., Borland, H., Bernier, R., Bookheimer, S. Y., Dapretto, M., Jack, A., et al. (2025) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2025.10.001 · Cited by 3 · see citing works
Trump watch: What are the US government’s plans for autism?
Looi, M.-K. (2025) · BMJ · doi:10.1136/bmj.r820 · Cited by 3 · see citing works
Kozlova, E. V., Denys, M. E., Bishay, A. E., Luna, C. N., Angelis, M. D., Campoy, L., Habbal, A., Lam, A. A., Luvsanravdan, N., Colton, A. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667293 · Cited by 2 · see citing works
Romney, J., Fife, S. T., Reitz, R., Piland, N., Soloski, K. L., Montgomery, A. L., & Wagner, K. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06847-3 · Cited by 2 · see citing works
Zaks, N., Kodesh, A., Zatorski, N., Wang, Y., Levine, S. Z., Sandin, S., Reichenberg, A., Schlessinger, A., & Janecka, M. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10071 · Cited by 2 · see citing works
Bradshaw, J. L., Richards, J. E., Yurkovic‐Harding, J., & McLaughlin, E. (2025) · Autism Research · doi:10.1002/aur.70114 · Cited by 2 · see citing works
Burton, J. M., Creaghead, N. A., Duncan, A. W., Silbert, N. H., Breit‐Smith, A., & Grether, S. M. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-07035-z · Cited by 2 · see citing works
Mocnik, S., Kumperščak, H. G., & Demšar, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1681412 · Cited by 2 · see citing works
Kayıtmazbatır, E. T., Güler, H. A., Duyan, Ş. A., Oflaz, A. B., & Bozkurt, B. (2025) · Medicina · doi:10.3390/medicina61101779 · Cited by 2 · see citing works
- Authors
- Shaw, K. A., Williams, S., Patrick, M. E., Valencia-Prado, M., Durkin, M. S., Howerton, E. M., Ladd-Acosta, C. M., Pas, E. T., Bakian, A. V., Bartholomew, P., Nieves-Muñoz, N., Sidwell, K., Alford, A., Bilder, D. A., DiRienzo, M., Fitzgerald, R. T., Furnier, S. M., Hudson, A. E., Pokoski, O. M., Shea, L., Tinker, S. C., Warren, Z., Zahorodny, W., Agosto-Rosa, H., Anbar, J., Chavez, K. Y., Esler, A., Forkner, A., Grzybowski, A., Agib, A. H., Hallas, L., Lopez, M., Magaña, S., Nguyen, R. H. N., Parker, J., Pierce, K., Protho, T., Torres, H., Vanegas, S. B., Vehorn, A., Zhang, M., Andrews, J., Greer, F., Hall-Lande, J., McArthur, D., Mitamura, M., Montes, A. J., Pettygrove, S., Shenouda, J., Skowyra, C., Washington, A., & Maenner, M. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of Wisconsin–Madison (US)
- Johns Hopkins University (US)
- University of Utah (US)
- University of California San Diego (US)
- National Center on Birth Defects and Developmental Disabilities (US)
- Rutgers New Jersey Medical School (US)
- Pennsylvania Department of Human Services (US)
- Washington University in St. Louis (US)
- University of Arkansas for Medical Sciences (US)
- Vanderbilt University Medical Center (US)
- Puerto Rico Department of Health (PR)
- University of Minnesota (US)
- The University of Texas at Austin (US)
- Arizona State University (US)
- University of Arizona (US)
- Corresponding author
- Shaw, Kelly A.
- ORCID
- Patrick, Mary E.
- Durkin, Maureen S.
- Howerton, Ellen M.
- Ladd-Acosta, Christine M.
- Pas, Elise T.
- Bakian, Amanda V.
- Alford, Amy
- Bilder, Deborah A.
- DiRienzo, Monica
- Fitzgerald, Robert T.
- Furnier, Sarah M.
- Pokoski, Olivia M.
- Shea, Lindsay
- Tinker, Sarah C.
- Warren, Zachary
- Zahorodny, Walter
- Anbar, Joshua
- Esler, Amy
- Lopez, Maya
- Magaña, Sandy
- Nguyen, Ruby H.N.
- Pierce, Karen
- Vanegas, Sandra B.
- Zhang, Minyu
- Andrews, Jennifer
- McArthur, Dedria
- Pettygrove, Sydney
- Shenouda, Josephine
- Washington, Anita
- Maenner, Matthew J.
- Venue
- MMWR. Surveillance Summaries
- Published
- 2025-04-17
- Volume
- 74
- Issue
- 2
- Pages
- 1-22
- ISSN
- 1545-8636 (ISSN-L)
- 1546-0738
- PMC
- PMC12011386
- OpenAlex
- W4409458169
- Semantic Scholar
- ce82e952834c1f4b32c7226767552851cc1f0430
- Cited by
- 867
- References
- 31
- Citations by year
- 2026: 615 · 2025: 252
- FWCI
- 491.83
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Surveillance Summaries (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
- Keywords
- autism spectrum disorder, autism prevalence, sex differences, racial and ethnic disparities, ASD subtypes, developmental disabilities, prevalence, early detection, autism screening
- MeSH terms
- Autism Spectrum Disorder, Child, Child, Preschool, Female, Humans, Male, Population Surveillance, United States, Prevalence, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review